Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database

BACKGROUND: The optimal treatment modality for patients with stage IA (T1N0M0) small-cell lung cancer (SCLC) is still unclear. METHODS: Patients who received surgical resection or chemo-radiotherapy (CRT) between January 2004 and December 2014 were identified from The Surveillance, Epidemiology and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shao-Feng, Zheng, Yu-Zhen, Li, Xiao-Qiang, Xu, Hai-Peng, Wang, Jun-Jie, Wang, Wei, Huang, Qing-Yuan, Wu, Da, Zhong, Chen-Xi, Fu, Shen-Shen, Yuan, Lian-Xiong, Wang, Si-Chao, Luo, Rui-Xing, Zhai, Wen-Yu, Yu, Ben-Tong, Zhu, Kun-Shou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661878/
https://www.ncbi.nlm.nih.gov/pubmed/33209872
http://dx.doi.org/10.21037/atm-20-5525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661878/
https://www.ncbi.nlm.nih.gov/pubmed/33209872
http://dx.doi.org/10.21037/atm-20-5525

Ejemplares similares